160 related articles for article (PubMed ID: 16770228)
1. Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging.
Truong MT; Pan T; Erasmus JJ
J Thorac Imaging; 2006 May; 21(2):111-22. PubMed ID: 16770228
[TBL] [Abstract][Full Text] [Related]
2. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
3. The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
Eschmann SM; Bitzer M; Paulsen F; Friedel G; Besenfelder H; Horger M; Reimold M; Dittmann H; Pfannenberg AC; Bares R
Nucl Med Commun; 2004 Sep; 25(9):909-15. PubMed ID: 15319596
[TBL] [Abstract][Full Text] [Related]
4. Extrathoracic PET/CT findings in thoracic malignancies.
Marom EM; Bruzzi JF; Truong MT
J Thorac Imaging; 2006 May; 21(2):154-66. PubMed ID: 16770232
[TBL] [Abstract][Full Text] [Related]
5. PET/CT in the thorax: pitfalls.
Truong MT; Viswanathan C; Carter BW; Mawlawi O; Marom EM
Radiol Clin North Am; 2014 Jan; 52(1):17-25. PubMed ID: 24267708
[TBL] [Abstract][Full Text] [Related]
6. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
Conrad GR; Sinha P
Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
[TBL] [Abstract][Full Text] [Related]
7. PET/CT imaging techniques, considerations, and artifacts.
Mawlawi O; Pan T; Macapinlac HA
J Thorac Imaging; 2006 May; 21(2):99-110. PubMed ID: 16770227
[TBL] [Abstract][Full Text] [Related]
8. PET/CT Interpretative Pitfalls in Thoracic Malignancies.
Shroff GS; Sabloff BS; Truong MT; Carter BW; Viswanathan C
Semin Ultrasound CT MR; 2018 Jun; 39(3):282-288. PubMed ID: 29807638
[TBL] [Abstract][Full Text] [Related]
9. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
Shammas A; Lim R; Charron M
Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
[TBL] [Abstract][Full Text] [Related]
10. PET/MRI and PET/CT in Lung Lesions and Thoracic Malignancies.
Flechsig P; Mehndiratta A; Haberkorn U; Kratochwil C; Giesel FL
Semin Nucl Med; 2015 Jul; 45(4):268-81. PubMed ID: 26050655
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
Gorospe L; Jover-Díaz R; Vicente-Bártulos A
Abdom Imaging; 2012 Dec; 37(6):1041-65. PubMed ID: 22349805
[TBL] [Abstract][Full Text] [Related]
12. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
13. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
Devic S; Tomic N; Faria S; Menard S; Lisbona R; Lehnert S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1555-62. PubMed ID: 20646840
[TBL] [Abstract][Full Text] [Related]
14. Nonrigid versus rigid registration of thoracic 18F-FDG PET and CT in patients with lung cancer: an intraindividual comparison of different breathing maneuvers.
Grgic A; Nestle U; Schaefer-Schuler A; Kremp S; Ballek E; Fleckenstein J; Rübe C; Kirsch CM; Hellwig D
J Nucl Med; 2009 Dec; 50(12):1921-6. PubMed ID: 19910420
[TBL] [Abstract][Full Text] [Related]
15. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
[TBL] [Abstract][Full Text] [Related]
16. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Aquino SL; Fischman AJ
Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
[TBL] [Abstract][Full Text] [Related]
17. Design of respiration averaged CT for attenuation correction of the PET data from PET/CT.
Chi PC; Mawlawi O; Nehmeh SA; Erdi YE; Balter PA; Luo D; Mohan R; Pan T
Med Phys; 2007 Jun; 34(6):2039-47. PubMed ID: 17654907
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in Interpretation of PET/CT in the Chest.
Strange C; Shroff GS; Truong MT; Rohren EM
Semin Ultrasound CT MR; 2021 Dec; 42(6):588-598. PubMed ID: 34895614
[TBL] [Abstract][Full Text] [Related]
19. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
20. Integrated positron emission tomography/computed tomography fusion imaging: an emerging gold standard in lung cancer.
Joshi SC; Pant I; Hamzah F; Kumar G; Shukla AN
Indian J Cancer; 2008; 45(4):137-41. PubMed ID: 19112200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
